Anne Samuel
Stock Analyst at JP Morgan
(3.56)
# 888
Out of 4,915 analysts
67
Total ratings
59.52%
Success rate
4.19%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $59.70 | +0.50% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $194.55 | -9.02% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $29.63 | +21.50% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $287.23 | -13.31% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $9.41 | +27.52% | 12 | Mar 10, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $22.83 | +0.74% | 7 | Jan 28, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $27.12 | +3.24% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $21.26 | -10.63% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $21.24 | -1.13% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $3.92 | +232.06% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $35.69 | -24.35% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $4.08 | +22.70% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $95.77 | +12.77% | 8 | Apr 2, 2024 |
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $59.70
Upside: +0.50%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $194.55
Upside: -9.02%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $29.63
Upside: +21.50%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $287.23
Upside: -13.31%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $9.41
Upside: +27.52%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $22.83
Upside: +0.74%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $27.12
Upside: +3.24%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $21.26
Upside: -10.63%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $21.24
Upside: -1.13%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $3.92
Upside: +232.06%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $35.69
Upside: -24.35%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $4.08
Upside: +22.70%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $95.77
Upside: +12.77%